Literature DB >> 28129127

Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor Response.

Brandon D Ng1, Dan Peer2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28129127      PMCID： PMC5363200          DOI： 10.1016/j.ymthe.2016.12.003

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

Review 1.  Current approaches in SELEX: An update to aptamer selection technology.

Authors:  Mariia Darmostuk; Silvie Rimpelova; Helena Gbelcova; Tomas Ruml
Journal:  Biotechnol Adv       Date:  2015-02-20       Impact factor: 14.227

2.  Aptamers: problems, solutions and prospects.

Authors:  A V Lakhin; V Z Tarantul; L V Gening
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

3.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

4.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.

Authors:  Erwei Song; Pengcheng Zhu; Sang-Kyung Lee; Dipanjan Chowdhury; Steven Kussman; Derek M Dykxhoorn; Yi Feng; Deborah Palliser; David B Weiner; Premlata Shankar; Wayne A Marasco; Judy Lieberman
Journal:  Nat Biotechnol       Date:  2005-05-22       Impact factor: 54.908

5.  Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity.

Authors:  Anugraha Rajagopalan; Alexey Berezhnoy; Brett Schrand; Yvonne Puplampu-Dove; Eli Gilboa
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 6.  Aptamers and aptamer targeted delivery.

Authors:  Amy C Yan; Matthew Levy
Journal:  RNA Biol       Date:  2009-07-18       Impact factor: 4.652

7.  Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.

Authors:  James O McNamara; Despina Kolonias; Fernando Pastor; Robert S Mittler; Lieping Chen; Paloma H Giangrande; Bruce Sullenger; Eli Gilboa
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 8.  Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools.

Authors:  Hunho Jo; Changill Ban
Journal:  Exp Mol Med       Date:  2016-05-06       Impact factor: 8.718

Review 9.  Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities.

Authors:  K M Morrissey; T M Yuraszeck; C-C Li; Y Zhang; S Kasichayanula
Journal:  Clin Transl Sci       Date:  2016-03-30       Impact factor: 4.689

10.  A review of therapeutic aptamer conjugates with emphasis on new approaches.

Authors:  John G Bruno
Journal:  Pharmaceuticals (Basel)       Date:  2013-03-19
View more
  1 in total

Review 1.  Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes.

Authors:  Shoshy Mizrahy; Inbal Hazan-Halevy; Niels Dammes; Dalit Landesman-Milo; Dan Peer
Journal:  Mol Ther       Date:  2017-04-06       Impact factor: 11.454
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.